LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
6.14
-0.16 (-2.54%)
At close: Oct 27, 2025, 4:00 PM EDT
6.15
+0.01 (0.16%)
After-hours: Oct 27, 2025, 7:24 PM EDT
LifeMD Revenue
LifeMD had revenue of $62.22M in the quarter ending June 30, 2025, with 22.81% growth. This brings the company's revenue in the last twelve months to $245.56M, up 37.74% year-over-year. In the year 2024, LifeMD had annual revenue of $212.45M with 39.27% growth.
Revenue (ttm)
$245.56M
Revenue Growth
+37.74%
P/S Ratio
1.07
Revenue / Employee
$799,882
Employees
307
Market Cap
291.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 212.45M | 59.91M | 39.27% |
| Dec 31, 2023 | 152.55M | 33.51M | 28.15% |
| Dec 31, 2022 | 119.03M | 26.16M | 28.16% |
| Dec 31, 2021 | 92.88M | 55.58M | 149.04% |
| Dec 31, 2020 | 37.29M | 24.83M | 199.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
LFMD News
- 3 days ago - LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman - PRNewsWire
- 4 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD - PRNewsWire
- 4 days ago - LifeMD to Report Third Quarter 2025 Financial Results on November 6 - GlobeNewsWire
- 5 days ago - LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women's Health Program - GlobeNewsWire
- 14 days ago - LifeMD (LFMD) Sued for Allegedly Misleading Investors on Growth Guidance, According to Hagens Berman - GlobeNewsWire
- 15 days ago - LFMD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD - GlobeNewsWire
- 17 days ago - Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman - PRNewsWire
- 18 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 25, 2025 in LifeMD, Inc. Lawsuit - LFMD - PRNewsWire